What the New FDA-Approved GLP-1 Pill from Eli Lilly Means for Everyday Weight Management Options

 

Quick Fact List on Foundayo (orforglipron):

  • Once-daily oral tablet
  • Approved for chronic weight management in eligible adults
  • Can be taken any time without food/water restrictions
  • Works alongside diet and physical activity
  • Common side effects reported in trials include nausea, diarrhea, constipation, vomiting, and in some cases hair loss (similar to the class)
  • Not for everyone — talk to a healthcare provider about suitability

What This Approval Could Mean for the Weight Loss Medication Market

 

For complete cooking times, go to the next page or click the Open button (>), and don't forget to SHARE with your Facebook friends.